{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:05:14Z","timestamp":1788973514833,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2015ZM165"],"award-info":[{"award-number":["2015ZM165"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Fund for Public Welfare Research and Capacity Building of Guangdong Province","award":["2014B020210001"],"award-info":[{"award-number":["2014B020210001"]}]},{"name":"University of Nicosia Medical School"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jphs.2019.01.016","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:23:36Z","timestamp":1552609416000},"page":"311-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Trimetazidine prevents diabetic cardiomyopathy by inhibiting Nox2\/TRPC3-induced oxidative stress"],"prefix":"10.1016","volume":"139","author":[{"given":"Sheng-Gao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jphs.2019.01.016_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.016_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jphs.2019.01.016_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jphs.2019.01.016_bib4","first-page":"9","article-title":"Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-\u03b2 dependent manner","volume":"2015","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jphs.2019.01.016_bib5","doi-asserted-by":"crossref","first-page":"37001","DOI":"10.1038\/srep37001","article-title":"TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling","volume":"6","author":"Kitajima","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.016_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-005-0077-2","article-title":"Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis","volume":"7","author":"Folmes","year":"2005","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.016_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cvr\/cvq181","article-title":"Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway","volume":"88","author":"Liu","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"3122\u2013130","key":"10.1016\/j.jphs.2019.01.016_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.metabol.2015.10.022","article-title":"The protective effect of trimetazidine on myocardial ischemia\/reperfusion injury through activating AMPK and ERK signaling pathway","volume":"65","author":"Liu","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jphs.2019.01.016_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijcard.2015.11.060","article-title":"Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure","volume":"203","author":"Lopatin","year":"2016","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jphs.2019.01.016_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mehy.2010.09.012","article-title":"Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy","volume":"76","author":"Wang","year":"2011","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.016_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12967-016-0849-1","article-title":"Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy","volume":"14","author":"Zhang","year":"2016","journal-title":"J\u00a0Transl Med"},{"issue":"12","key":"10.1016\/j.jphs.2019.01.016_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1440-1681.2005.04293.x","article-title":"Cardiac mitochondrial alterations induced by insulin deficiency and hyperinsulinaemia in rats: targeting membrane homeostasis with trimetazidine","volume":"32","author":"Ovide-Bordeaux","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"10.1016\/j.jphs.2019.01.016_bib13","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/db06-1662","article-title":"Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jphs.2019.01.016_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.jphs.2019.01.016_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1139\/Y07-036","article-title":"The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts","volume":"85","author":"Onay-Besikci","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"10.1016\/j.jphs.2019.01.016_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jphs.2014.12.007","article-title":"Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats","volume":"127","author":"Liu","year":"2015","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.jphs.2019.01.016_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2019.01.016_bib18","doi-asserted-by":"crossref","first-page":"461967","DOI":"10.1155\/2013\/461967","article-title":"Alteration of energy substrates and ROS production in diabetic cardiomyopathy","volume":"2013","author":"Lorenzo","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.016_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2011.04.124","article-title":"TRPC3-mediated Ca2+ influx contributes to Rac1-mediated production of reactive oxygen species in MLP-deficient mouse hearts","volume":"409","author":"Kitajima","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2019.01.016_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2013.02.021","article-title":"Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice","volume":"60","author":"Huynh","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.jphs.2019.01.016_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jphs.2017.10.007","article-title":"Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity","volume":"135","author":"Niu","year":"2017","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.jphs.2019.01.016_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bph.13386","article-title":"Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1","volume":"173","author":"Chen","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"15","key":"10.1016\/j.jphs.2019.01.016_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93358","article-title":"TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy","volume":"2","author":"Shimauchi","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.jphs.2019.01.016_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.jphs.2019.01.016_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00125-002-0829-2","article-title":"Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors","volume":"45","author":"M\u00fcller","year":"2002","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.016_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-016-0399-8","article-title":"Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.jphs.2019.01.016_bib27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/db06-0922","article-title":"Genetic variation, C-reactive protein levels, and incidence of diabetes","volume":"56","author":"Dehghan","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jphs.2019.01.016_bib28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland coronary prevention study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jphs.2019.01.016_bib29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2019.01.016_bib30","first-page":"137","article-title":"Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110\u03b1) signaling","volume":"87","author":"DeBosch","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.jphs.2019.01.016_bib31","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s00125-012-2720-0","article-title":"Enhanced phosphoinositide 3-kinase (p110 \u03b1) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes","volume":"55","author":"Ritchie","year":"2012","journal-title":"Diabetologia"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319300349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319300349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:58:39Z","timestamp":1761163119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861319300349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1347861319300349"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2019.01.016","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimetazidine prevents diabetic cardiomyopathy by inhibiting Nox2\/TRPC3-induced oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2019.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}